search
Back to results

Laparoscopic Sacropexy and Vaginal Natural Orifice Transluminal Endoscopic Surgery Shull Suspension Comparison Trial (V-PULSE)

Primary Purpose

Pelvic Organ Prolapse

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Laparoscopic cervicosacropexy
Shull technique via V-NOTES
Sponsored by
Azienda Ospedaliero, Universitaria Pisana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Organ Prolapse

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: consecutive women referred to one of the participating centers with symptomatic stage 2 or greater (point C≥ -1 pelvic organ prolapse quantification POP-Q) apical prolapse (uterovaginal) with or without anterior and posterior compartment prolapse will be eligible for inclusion (Criteria for which patients in clinical practice are candidates for one of the two interventions under study) Exclusion Criteria: age <18 years, BMI > 30, previous hysterectomy, inability to comprehend questionnaires, to give informed consent and to return for review, unable to undergo general anesthesia, prior laparoscopic prolapse repair or vaginal mesh prolapse procedure, desire for future pregnancy or current pregnancy diagnosis severe respiratory comorbidity, ASA III patients, need for concomitant anti-incontinence procedure.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    laparoscopic cervicosacropexy (CSP)

    Shull technique via V-NOTES (VNS)

    Arm Description

    Outcomes

    Primary Outcome Measures

    operating time
    from skin/vaginal incision to end of skin/vaginal suture
    post-operative pain
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    post-operative pain
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    post-operative pain
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    post-operative pain
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    time to mobilization with standing
    Time it takes the patient to mobilize to standing independently
    hospital stay
    hours of post-operative stay
    patient satisfaction
    assessed by P-QoL (prolapse quality of life) validated questionnaire
    patient satisfaction
    assessed by P-QoL validated questionnaire
    patient satisfaction
    assessed by PGI-I (patient global impression of improvement) validated questionnaires
    patient satisfaction
    assessed by PGI-I validated questionnaires
    patient satisfaction
    assessed by validated questionnaires (VAS, visual analogic scale from 0 to 10)
    patient satisfaction
    assessed by validated questionnaires (VAS, visual analogic scale from 0 to 10)
    sexual function
    assessed by FSFI (female sexual function index) questionnaire
    sexual function
    assessed by FSFI questionnaire
    sexual function
    assessed by TVL (total vaginal lenght) measure
    sexual function
    assessed by TVL measure
    recurrence of prolapse in apical compartment
    POP-Q (Pelvic Organ Prolapse Quantification system) C point measure
    recurrence of prolapse in apical compartment
    POP-Q (Pelvic Organ Prolapse Quantification system) C point measure
    recurrence of prolapse in the anterior and posterior compartments when present
    postoperative complications
    assessed using Clavien-Dindo classification
    anesthesiological parameters
    End tidal CO2 (carbon dioxide) assessement
    anesthesiological parameters
    SpO2 (oxygen saturation) assessement
    anesthesiological parameters
    blood pressure assessement (measured in mmHg)
    anesthesiological parameters
    intraoperative blood loss assessement (measured in milliliters)
    anesthesiological parameters
    degrees of Trendelemburg assessement

    Secondary Outcome Measures

    Full Information

    First Posted
    April 20, 2023
    Last Updated
    May 3, 2023
    Sponsor
    Azienda Ospedaliero, Universitaria Pisana
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05856201
    Brief Title
    Laparoscopic Sacropexy and Vaginal Natural Orifice Transluminal Endoscopic Surgery Shull Suspension Comparison Trial
    Acronym
    V-PULSE
    Official Title
    Laparoscopic Supracervical Hysterectomy With Cervicosacropexy and Vaginally Assisted NOTES Hysterectomy With Uterosacral Ligament Suspension (Shull Technique): a Randomized Multicentric Prospective Comparison Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    May 2023 (Anticipated)
    Primary Completion Date
    September 2023 (Anticipated)
    Study Completion Date
    December 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Azienda Ospedaliero, Universitaria Pisana

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This is a prospective, randomized multicenter study whose objective is to compare two surgical techniques routinely used at our center for the correction of pelvic organ prolapse (laparoscopic cervicosacropexis versus colposuspension sec. Shull using v-NOTES).
    Detailed Description
    patients with pelvic organ prolapse with a stage greater than or equal to stage 2 for the apical compartment who are candidates for surgical correction will be randomized and assigned to one of two treatment groups. The aim is to compare the anatomical, surgical and anesthesiological outcomes between these two surgical techniques, both of which are commonly used in clinical practice for the correction of this type of prolapse.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pelvic Organ Prolapse

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    We will perform a interventional, no profit, prospective, randomized 1:1 multicentre, controlled trial with participating tertiary referral hospital centers in Italy, to compare the laparoscopic cervicosacropexy (CSP) and Shull technique via V-NOTES (VNS) in the management of apical prolapse.
    Masking
    InvestigatorOutcomes Assessor
    Masking Description
    The 6-week examination and review will be performed by the surgeon with all study data and future visits completed by blinded co-authors (Different surgeon or Urogynecology fellows) who will be unaware of group allocation.
    Allocation
    Randomized
    Enrollment
    90 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    laparoscopic cervicosacropexy (CSP)
    Arm Type
    Active Comparator
    Arm Title
    Shull technique via V-NOTES (VNS)
    Arm Type
    Active Comparator
    Intervention Type
    Procedure
    Intervention Name(s)
    Laparoscopic cervicosacropexy
    Intervention Description
    The first step consists of a supracervical hysterectomy with morcellation. Anterior and posterior dissection of the vesicovaginal and rectovaginal space. Placing a flexible blade or a Breisky blade in the vagina which is manipulated by the assistant in order to improve exposure of the tissue planes. The retroperitoneum will then be opened from sacral promontory to cervix with the incision just medial to the uterosacral ligament. A low-weight preshaped Y-shaped polypropylene mesh will be secured to the anterior and posterior vagina with four to six separated absorbable 2.0 polyglactin sutures and two nonabsorbable 2.0 prolene sutures can be placed at the level of the remaining cervix. The mesh will be attached to the sacral promontory using two or three nonabsorbable monofilament 2.0 prolene suture. The retroperitoneal space will be closed with continuous 2.0 polyglactin suture or barbed 2.0 absorbable suture material.
    Intervention Type
    Procedure
    Intervention Name(s)
    Shull technique via V-NOTES
    Intervention Description
    Using a cold-bladed scalpel, pericervical colpotomy and subsequent opening of the Douglas and vesico-uterine space is performed. The following step is forcipressure and section of uterosacral ligaments bilaterally with cold blade scissors and ligation in Polysorb 0. A v-PATH® wall retractor is placed, after insertion of three trocars. Total hysterectomy is then performed by standard V-NOTES technique. After transperitoneal visualization of the ureters bilaterally, the peritoneum is incised between the ureters and the uterosacral ligaments, which are thus bilaterally isolated, and three points in polydioxanone 2/0 are placed per side. The v-PATH wall retractor is then removed. Finally the suspension of the vaginal vault at the uterosacral ligaments is made according to Shull technique. Eventual fascial corrections of concomitant anterior or posterior defects will be associated if needed.
    Primary Outcome Measure Information:
    Title
    operating time
    Description
    from skin/vaginal incision to end of skin/vaginal suture
    Time Frame
    intraoperative
    Title
    post-operative pain
    Description
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    Time Frame
    at 4 hours post-operative
    Title
    post-operative pain
    Description
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    Time Frame
    at 8 hours post-operative
    Title
    post-operative pain
    Description
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    Time Frame
    at 1 month post-operative
    Title
    post-operative pain
    Description
    VAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
    Time Frame
    at 12 hours post-operative
    Title
    time to mobilization with standing
    Description
    Time it takes the patient to mobilize to standing independently
    Time Frame
    immediately post-operative
    Title
    hospital stay
    Description
    hours of post-operative stay
    Time Frame
    immediately post-operative
    Title
    patient satisfaction
    Description
    assessed by P-QoL (prolapse quality of life) validated questionnaire
    Time Frame
    at 6 weeks
    Title
    patient satisfaction
    Description
    assessed by P-QoL validated questionnaire
    Time Frame
    at 3 months
    Title
    patient satisfaction
    Description
    assessed by PGI-I (patient global impression of improvement) validated questionnaires
    Time Frame
    at 6 weeks
    Title
    patient satisfaction
    Description
    assessed by PGI-I validated questionnaires
    Time Frame
    at 3 months
    Title
    patient satisfaction
    Description
    assessed by validated questionnaires (VAS, visual analogic scale from 0 to 10)
    Time Frame
    at 6 weeks
    Title
    patient satisfaction
    Description
    assessed by validated questionnaires (VAS, visual analogic scale from 0 to 10)
    Time Frame
    at 3 months
    Title
    sexual function
    Description
    assessed by FSFI (female sexual function index) questionnaire
    Time Frame
    at 6 weeks
    Title
    sexual function
    Description
    assessed by FSFI questionnaire
    Time Frame
    at 3 months
    Title
    sexual function
    Description
    assessed by TVL (total vaginal lenght) measure
    Time Frame
    at 6 weeks
    Title
    sexual function
    Description
    assessed by TVL measure
    Time Frame
    3 months
    Title
    recurrence of prolapse in apical compartment
    Description
    POP-Q (Pelvic Organ Prolapse Quantification system) C point measure
    Time Frame
    at 6 weeks and 3 months;
    Title
    recurrence of prolapse in apical compartment
    Description
    POP-Q (Pelvic Organ Prolapse Quantification system) C point measure
    Time Frame
    at 6 weeks
    Title
    recurrence of prolapse in the anterior and posterior compartments when present
    Time Frame
    at 3 months;
    Title
    postoperative complications
    Description
    assessed using Clavien-Dindo classification
    Time Frame
    from surgery to 3 motnhs follow.up
    Title
    anesthesiological parameters
    Description
    End tidal CO2 (carbon dioxide) assessement
    Time Frame
    intraoperative
    Title
    anesthesiological parameters
    Description
    SpO2 (oxygen saturation) assessement
    Time Frame
    intraoperative
    Title
    anesthesiological parameters
    Description
    blood pressure assessement (measured in mmHg)
    Time Frame
    intraoperative
    Title
    anesthesiological parameters
    Description
    intraoperative blood loss assessement (measured in milliliters)
    Time Frame
    intraoperative
    Title
    anesthesiological parameters
    Description
    degrees of Trendelemburg assessement
    Time Frame
    intraoperative

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: consecutive women referred to one of the participating centers with symptomatic stage 2 or greater (point C≥ -1 pelvic organ prolapse quantification POP-Q) apical prolapse (uterovaginal) with or without anterior and posterior compartment prolapse will be eligible for inclusion (Criteria for which patients in clinical practice are candidates for one of the two interventions under study) Exclusion Criteria: age <18 years, BMI > 30, previous hysterectomy, inability to comprehend questionnaires, to give informed consent and to return for review, unable to undergo general anesthesia, prior laparoscopic prolapse repair or vaginal mesh prolapse procedure, desire for future pregnancy or current pregnancy diagnosis severe respiratory comorbidity, ASA III patients, need for concomitant anti-incontinence procedure.

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Laparoscopic Sacropexy and Vaginal Natural Orifice Transluminal Endoscopic Surgery Shull Suspension Comparison Trial

    We'll reach out to this number within 24 hrs